He will lead Roche in designing a patient-centric approach to address the diabetes burden in the the IMEA region
Roche has appointed Omar Sherief Mohammad as Head – India, Middle East and Africa (IMEA) within the Roche Diabetes Care (RDC) Global Commercial Organisation, based in Mumbai. In this new capacity, he will play a key role in the shaping and executing of the overall commercial go-to-market strategy, responsible for setting the strategic direction for IMEA, in alignment with the Global Commercial Organisation as well as the overall RDC strategy, a statement from the company said.
In this newly-created role, Sherief will have direct oversight of IMEA and the RDC General Managers/Country Heads of these markets will directly report to him. He will also be General Manager in India, it added.
The statement also notified that prior to this appointment, Sherief has been General Manager RDC India since September 2019.
Speaking about the new appointment, he said, “I strongly feel that there is a need for improving access to care in order to support the under-privileged section of the community by creating a holistic ecosystem for screening, awareness and education programmes. I look forward to leading my teams across the IMEA region towards dedicating efforts to bend the curve of diabetes in terms of prevalence and adding value by bringing true relief for people with diabetes.”
Sherief has two decades of experience in pharmaceutical sector, primarily in diabetes care, in India, global marketing in Denmark and emerging Asian markets. Prior to joining Roche, he was the VP and GM of Novo Nordisk, Vietnam and other Southeast Asia emerging markets, mentioned the statement.
As the head of IMEA, he will steer the countries under his charge to amplify this patient-centric approach and collaborate with various stakeholders to address the burden of diabetes in the region.